Synthesis of


Journal

Organic letters
ISSN: 1523-7052
Titre abrégé: Org Lett
Pays: United States
ID NLM: 100890393

Informations de publication

Date de publication:
17 02 2023
Historique:
pubmed: 2 2 2023
medline: 22 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

A concise, transition-metal and protection-free synthesis of

Identifiants

pubmed: 36723667
doi: 10.1021/acs.orglett.2c04266
pmc: PMC9942190
doi:

Substances chimiques

adagrasib 8EOO6HQF8Y
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2
Piperazines 0
Acetonitriles 0
KRAS protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

944-949

Références

J Med Chem. 2020 Jul 9;63(13):6679-6693
pubmed: 32250617
Front Oncol. 2022 Feb 16;12:796832
pubmed: 35251972
Cancer Discov. 2020 Jan;10(1):54-71
pubmed: 31658955
Org Lett. 2022 May 27;24(20):3736-3740
pubmed: 35559611
J Clin Oncol. 2022 Aug 10;40(23):2530-2538
pubmed: 35167329
Nature. 2022 Oct;610(7933):620-622
pubmed: 36284185
N Engl J Med. 2022 Jul 14;387(2):120-131
pubmed: 35658005
Org Lett. 2015 Oct 2;17(19):4930-2
pubmed: 26360817
Signal Transduct Target Ther. 2021 Nov 15;6(1):386
pubmed: 34776511

Auteurs

Cheng-Yi Chen (CY)

Chemical Process R&D, Mirati Therapeutics, San Diego, California 92121, United States.

Zhichao Lu (Z)

Chemical Process R&D, Mirati Therapeutics, San Diego, California 92121, United States.

Thomas Scattolin (T)

Chemical Process R&D, Mirati Therapeutics, San Diego, California 92121, United States.

Chengsheng Chen (C)

Chemical Process R&D, Mirati Therapeutics, San Diego, California 92121, United States.

Yonghong Gan (Y)

Chemical Process R&D, Mirati Therapeutics, San Diego, California 92121, United States.

Mark McLaughlin (M)

Chemical Process R&D, Mirati Therapeutics, San Diego, California 92121, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH